Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications
- PMID: 25275265
Persistent remission of Graves` disease or evolution from Graves' disease to Hashimoto's thyroiditis in childhood - a report of 6 cases and clinical implications
Abstract
Background: The main clinical manifestations of autoimmune thyroid diseases are Graves' disease (GD) and Hashimoto's thyroiditis (HT). Graves' disease is the cause of most cases of hyperthyroidism in childhood. Indications for radical therapy (surgery or 131I treatment) in children are still a matter of discussion, as sustained (sometimes very long) remission of GD is possible, while the radical therapy almost always leads to hypothyroidism. Spontaneous evolution from GD with hyperthyroidism to HT with hypothyroidism may also be observed.
Objective: The aim of the study was to analyze the clinical course of 6 cases of hyperthyroid girls with GD in whom a normalization of previously increased autoantibodies against thyrotropin (TSH) receptor (anti-TSHR) was observed together with a significant increase in autoantibodies against thyroid peroxidase (anti-TPO) and thyroglobulin (anti-Tg), with concomitant hypo- or euthyroidism but no recurrence of hyperthyroidism.
Subjects: Patients' age at diagnosis ranged from 5.0 to 16.5 years. Two (2) patients had Turner syndrome, another one (1), diabetic, was on insulin therapy.
Results: In all the girls, antithyroid drugs were administered and euthyroid state was achieved during the first 2.0-3.5 months of the treatment. Mild side effects were observed in only one case. The therapy was continued up to 1.5-4.0 years. Relapses during the therapy were observed in 2 cases. Up to now, no relapses have been observed for 0.5-7.5 years since the therapy withdrawal in 5 patients (1 patient was lost to follow-up), 2 patients are currently treated with levothyroxine due to hypothyroidism.
Conclusions: It seems that the prolonged pharmacotherapy with antithyroid drugs, followed by observation after remission of hyperthyroidism, may be an appropriate therapeutic option at least in some children with GD as they can be cured without radical therapy and the potential risks of such treatment.
Similar articles
-
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11. Thyroid. 2011. PMID: 21834677
-
Metamorphic thyroid autoimmunity in Down Syndrome: from Hashimoto's thyroiditis to Graves' disease and beyond.Ital J Pediatr. 2015 Nov 11;41:87. doi: 10.1186/s13052-015-0197-4. Ital J Pediatr. 2015. PMID: 26558364 Free PMC article.
-
Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism.Arch Intern Med. 1990 May;150(5):1105-9. Arch Intern Med. 1990. PMID: 1691909
-
Remission of Graves' hyperthyroidism treated with methimazole.Rev Invest Clin. 2002 Jul-Aug;54(4):307-10. Rev Invest Clin. 2002. PMID: 12415954 Review.
-
Autoimmune Thyroiditis Shifting from Hashimoto's Thyroiditis to Graves' Disease.Medicina (Kaunas). 2023 Apr 13;59(4):757. doi: 10.3390/medicina59040757. Medicina (Kaunas). 2023. PMID: 37109715 Free PMC article. Review.
Cited by
-
Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy.Endocrinol Metab (Seoul). 2019 Sep;34(3):268-274. doi: 10.3803/EnM.2019.34.3.268. Endocrinol Metab (Seoul). 2019. PMID: 31565879 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous